Share on Pinterest Ozempic, the active ingredient of which is semaglutide, can also reduce the risk of heart disease, according to research. Steve Christo – Corbis/Corbis via Getty Images ...

Patients with obesity who took semaglutide had lower risk for fractures vs. those who had sleeve gastrectomy. More research is needed to determine the relationship between semaglutide and bone health.

A new study has found a significant association between the use of GLP-1s such as Ozempic and Wegovy with a higher risk of developing a serious eye condition in patients with diabetes. Here are four t ...

Bank early Saturday raised the reserve requirement ratio to 18% Turkey’s central bank raised the reserve requirement ratios on banks’ short term liabilities abroad in a bid to discourage local ...

The combination study is designed to evaluate the safety and preliminary efficacy of a single-dose of ultra-long-acting subcutaneously administered ASC47 in combination with four doses of semaglutide ...

Semaglutide, sold under brand names like Ozempic, Rybelsus, and Wegovy, belongs to a class of medications called GLP-1 receptor agonists. While FDA-approved for managing diabetes and aiding weight ...

Two drugs—tirzepatide and semaglutide—have shown striking results in helping people lose weight and keep it off. But until now, no one had directly compared their performance in people without ...

3️⃣ Semaglutide crackdown: Shortages of Ozempic and other GLP-1 drugs for weight loss and diabetes allowed pharmacies to sell off-brand products not approved by the US Food and Drug ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight – without causing nausea. The discovery, made at the University of Gothenburg, could ...

Semaglutide, known primarily for diabetes management and weight reduction, is demonstrating remarkable cardiovascular benefits that begin surprisingly early in treatment and persist long-term.

Veru's Phase 2b study shows enobosarm combined with semaglutide improves safety, reduces gastrointestinal issues, and promotes fat loss while preserving lean mass. There is a potential risk that ...

The move effectively ends remote work at JPL, which had been a fixture at the Pasadena, California lab since the pandemic. Many of JPL's nearly 5,500 employees work on hybrid, or fully-remote ...